Grant Pickering serves as Executive at Vaxcyte, Inc., where they oversee executive responsibilities. Since joining the company, Grant Pickering has executed 191 insider transactions totaling $25.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2024 involved selling 363 shares valued at $27.1K.
Grant Pickering currently holds 400,908 shares of Vaxcyte, Inc. (PCVX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Grant Pickering has been a net seller of PCVX stock. They have purchased $60.4K and sold $25.5M worth of shares.
Grant Pickering's most recent insider trade was on Mar 1, 2024, when they sold 363 shares at $74.69 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |
| Feb 26, 2024 | PCVX | $53.7K | Option Exercise | 30,000 | $1.79 | Planned |
| Feb 26, 2024 | PCVX | $2.4M | Sale | 30,000 | $79.03 | Planned |
| Feb 23, 2024 | PCVX | $530.2K | Sale | 6,980 | $75.96 | Planned |
| Feb 23, 2024 | PCVX | $26.9K | Option Exercise | 15,000 | $1.79 | Planned |
| Feb 23, 2024 | PCVX | $426.7K | Sale | 5,545 | $76.95 | Planned |
| Feb 23, 2024 | PCVX | $9.2K | Sale | 119 | $77.56 | Planned |
| Feb 23, 2024 | PCVX | $177.1K | Sale | 2,356 | $75.15 | Planned |
| Feb 1, 2024 | PCVX | $17.7K | Sale | 238 | $74.56 | Planned |
| Feb 1, 2024 | PCVX | $21.2K | Sale | 281 | $75.49 | Planned |
| Feb 1, 2024 | PCVX | $48.0K | Sale | 655 | $73.34 | Planned |
| Feb 1, 2024 | PCVX | $9.6K | Sale | 134 | $71.93 | Planned |
| Feb 1, 2024 | PCVX | $19.2K | Sale | 255 | $75.47 | Planned |
| Feb 1, 2024 | PCVX | $32.9K | Sale | 443 | $74.37 | Planned |
| Feb 1, 2024 | PCVX | $36.0K | Sale | 491 | $73.26 | Planned |
| Feb 1, 2024 | PCVX | $8.6K | Sale | 119 | $71.93 | Planned |
| Jan 29, 2024 | PCVX | $53.7K | Option Exercise | 30,000 | $1.79 | Planned |
| Jan 29, 2024 | PCVX | $2.0M | Sale | 30,000 | $66.03 | Planned |
| Jan 23, 2024 | PCVX | $120 | Option Exercise | 3,000 | $0.04 | Planned |
| Jan 23, 2024 | PCVX | $21.5K | Option Exercise | 12,000 | $1.79 | Planned |
| Jan 23, 2024 | PCVX | $641.0K | Sale | 10,023 | $63.95 | Planned |
| Jan 23, 2024 | PCVX | $132.1K | Sale | 2,039 | $64.78 | Planned |
| Jan 23, 2024 | PCVX | $185.7K | Sale | 2,938 | $63.22 | Planned |
| Jan 2, 2024 | PCVX | $37.8K | Sale | 594 | $63.65 | Planned |
| Jan 2, 2024 | PCVX | $37.8K | Sale | 587 | $64.33 | Planned |
| Jan 2, 2024 | PCVX | $6.1K | Sale | 97 | $62.91 | Planned |
| Jan 2, 2024 | PCVX | $36.2K | Sale | 568 | $63.68 | Planned |
| Jan 2, 2024 | PCVX | $41.3K | Sale | 643 | $64.24 | Planned |
| Jan 2, 2024 | PCVX | $8.0K | Sale | 127 | $62.93 | Planned |